Sofinnova Ventures »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2025-09-30 $48M 3.1M 15.13
2025-06-30 $46M 4.1M 11.27
2025-03-31 $13M 1.3M 10.09
2024-06-30 $20M 1.9M 10.57
2024-03-31 $11M 1.0M 10.54

More positions owned by Sofinnova Ventures

Natera (NTRA)
Gilead Sciences (GILD)
United Therapeutics Corporation Put Option (UTHR)
Vera Therapeutics Cl A (VERA)
Jazz Pharmaceuticals Shs Usd (JAZZ)
AstraZeneca Sponsored Adr (AZN)
Rapport Therapeutics (RAPP)
Boston Scientific Corporation (BSX)
Uniqure NV SHS Call Option (QURE)
Dex (DXCM)
Intuitive Surgical (ISRG)
Axsome Therapeutics (AXSM)
Roivant Sciences SHS (ROIV)
iShares TR Ishares Biotech Put Option (IBB)
Vertex Pharmaceuticals Incorporated (VRTX)

View all positions for Sofinnova Ventures

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

FMR
Morgan Stanley
Sb Investment Advisers
BlackRock
Vanguard Group
QVT Financial
Viking Global Investors
Rubric Capital Management
State Street Corporation
Two Seas Capital
Patient Square Capital
Dimensional Fund Advisors
Geode Capital Management
Perceptive Advisors
Adage Capital Partners GP

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017